Cocrystal Pharma Inc

COCP

Company Profile

  • Business description

    Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

  • Contact

    19805 North Creek Parkway
    BothellWA98011
    USA

    T: +1 877 262-7123

    E: [email protected]

    https://www.cocrystalpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    11

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.4015.50-0.18%
CAC 407,712.6316.360.21%
DAX 4023,960.52173.070.73%
Dow JONES (US)44,828.53344.110.77%
FTSE 1008,836.1913.280.15%
HKSE23,887.8328.23-0.12%
NASDAQ20,601.10207.971.02%
Nikkei 22539,587.68223.20-0.56%
NZX 50 Index12,764.951.65-0.01%
S&P 5006,279.3551.930.83%
S&P/ASX 2008,589.3013.70-0.16%
SSE Composite Index3,473.130.810.02%

Market Movers